S

Sarah Cannon Research Institute

Community-based oncology clinical research organization

Data Coordinator

Clinical Research OperationsPosted on Nov 9
Full-timeDenver, CO, USA$23 - $27 /hrIn-person

About the Job

Requirements

  • Knowledge of scientific, medical, and regulatory terms.
  • Knowledge of Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP).
  • Strong written and oral English skills.

Responsibilities

  • Support Study Coordinators in meeting industry trial data deadlines.
  • Obtain source documentation for patients enrolled in clinical trials.
  • Assist Study Coordinators with case report form completion and query resolution.
  • Assist with Serious Adverse Event (SAE) reporting and tracking.
  • Create and maintain patient visit tracking spreadsheets for Study Coordinators.
  • Maintain and archive study administrative files.
  • Complete assigned special procedural projects to enhance the functioning of Drug Development Data Operations.
  • Assess adherence to SCRI standard operating procedures (SOPs), Good Clinical Practice (GCP), and International Council for Harmonisation (ICH) regulations and guidelines throughout clinical trials.

Desired Qualifications

  • Healthcare experience, clinical trials support, or pharmaceutical industry experience.

About the Company

Sarah Cannon Research Institute

Community-based oncology clinical research organization

Sarah Cannon Research Institute (SCRI) is a global oncology research organization that conducts cancer clinical trials in community settings, partnering with pharmaceutical and biotech sponsors, physicians, and patients to develop new treatments. It works as an oncology-focused contract research organization (CRO) and centralized site management organization (SMO), running trials across more than 200 locations with roughly 1,500 research physicians, and applies technology such as its Accelero platform to personalized-medicine studies. Over more than 30 years it has completed more than 900 first-in-human trials across early- to late-phase research. What sets SCRI apart is this community-based model paired with early-phase depth, which has helped advance most new cancer therapies the FDA approved in the past decade. The goal is to accelerate oncology research from early trials to approval and bring advanced cancer treatments to patients.

Company size
1-10
Company stage
Not listed
Total funding
Not listed
Headquarters
Beach Haven, NJ
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at Sarah Cannon Research Institute

See more jobs